Publications by authors named "Tim Grob"

Claim this Profile
M
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia.
Dorien Pastoors, Marije Havermans, Roger Mulet-Lazaro, Leonie Smeenk, Sophie Ottema, Tim Grob

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advantages of a genomic DNA-based next-generation sequencing assay for detection of mutant NPM1 measurable residual disease in AML.
Christian M Vonk, Tim Grob, Melissa Rijken, François G Kavelaars, Jolinda M L Konijnenburg

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double mutant DNMT3A AML: a unique subtype experiencing increased DNA damage and poor prognosis.
Emma L Boertjes, Sanne Massaar, Annelieke Zeilemaker, Jolinda Konijnenburg, Melissa Rijken, Tim Grob

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic relevance of molecular measurable residual disease detection in AML with mutated .
Christian M Vonk, Emma L Boertjes, Francois G Kavelaars, Melissa Rijken, Jolinda M L Konijnenburg, Tim Grob

Hemasphere· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of -Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia.
Tim Grob, Mathijs A Sanders, Christian M Vonk, Franҫois G Kavelaars, Melissa Rijken

J Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome.
Tim Grob, Adil S A Al Hinai, Mathijs A Sanders, François G Kavelaars, Melissa Rijken

Blood· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia.
Leonie Smeenk, Sophie Ottema, Roger Mulet-Lazaro, Anja Ebert, Marije Havermans, Tim Grob

Cancer Discov· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PPM1D mutations appear in complete remission after exposure to chemotherapy without predicting emerging AML relapse.
Adil S A Al Hinai, Tim Grob, Melissa Rijken, François G Kavelaars, Annelieke Zeilemaker

Leukemia· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLT3-ITD mutations in acute myeloid leukaemia - molecular characteristics, distribution and numerical variation.
Caroline Engen, Monica Hellesøy, Tim Grob, Adil Al Hinai, Atle Brendehaug

Mol Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex disparity in acute myeloid leukaemia with FLT3 internal tandem duplication mutations: implications for prognosis.
Monica Hellesøy, Caroline Engen, Tim Grob, Bob Löwenberg, Peter J M Valk

Mol Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation.
Burak Kalin, Yvette van Norden, Michel van Gelder, Dimitri Breems, Johan Maertens, Tim Grob

Blood Adv· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Archived bone marrow smears are an excellent source for NGS-based mutation detection in acute myeloid leukemia.
Adil S A Al Hinai, Tim Grob, François G Kavelaars, Melissa Rijken, Annelieke Zeilemaker

Leukemia· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia.
Sophie Ottema, Roger Mulet-Lazaro, H Berna Beverloo, Claudia Erpelinck, Stanley van Herk, Tim Grob

Blood· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD34CD38 leukemic stem cell frequency to predict outcome in acute myeloid leukemia.
Wendelien Zeijlemaker, Tim Grob, Rosa Meijer, Diana Hanekamp, Angèle Kelder

Leukemia· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Landscape of -PTD AML: Concurrent Mutations, Gene Expression Signatures, and Clinical Outcome.
Adil S A Al Hinai, Marta Pratcorona, Tim Grob, François G Kavelaars, Elena Bussaglia

Hemasphere· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
Mojca Jongen-Lavrencic, Tim Grob, Diana Hanekamp, François G Kavelaars, Adil Al Hinai

N Engl J Med· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Localized RhoA GTPase activity regulates dynamics of endothelial monolayer integrity.
Robert Szulcek, Cora M L Beckers, Jasmina Hodzic, Jelle de Wit, Zhenlong Chen, Tim Grob

Cardiovasc Res· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis